Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
RXO Stock Forecast 2025-2026
$17.27
Current Price
$2.83B
Market Cap
Buy 4
Hold 14
Sell 3
Wall St Analyst Ratings
Distance to RXO Price Targets
+33.2%
To High Target of $23.00
-7.4%
To Median Target of $16.00
-42.1%
To Low Target of $10.00
RXO Price Momentum
+19.4%
1 Week Change
+30.4%
1 Month Change
-16.1%
1 Year Change
-27.6%
Year-to-Date Change
-47.4%
From 52W High of $32.82
+41.7%
From 52W Low of $12.19
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching RXO (RXO) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on RXO and similar high-potential opportunities.
Latest RXO Stock Price Targets & Analyst Predictions
Based on our analysis of 23 Wall Street analysts, RXO has a neutral consensus with a median price target of $16.00 (ranging from $10.00 to $23.00). The overall analyst rating is Buy (6.2/10). Currently trading at $17.27, the median forecast implies a -7.4% downside. This outlook is supported by 4 Buy, 14 Hold, and 3 Sell ratings.
The most optimistic forecast comes from Jeffrey Kauffman at Vertical Research, projecting a 33.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
RXO Analyst Ratings
4
Buy
14
Hold
3
Sell
RXO Price Target Range
Low
$10.00
Average
$16.00
High
$23.00
Current: $17.27
Latest RXO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for RXO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 16, 2025 | B of A Securities | Ken Hoexter | Neutral | Maintains | $18.00 |
| May 8, 2025 | Stifel | J. Bruce Chan | Hold | Maintains | $14.00 |
| May 8, 2025 | Wells Fargo | Christian Wetherbee | Equal-Weight | Maintains | $15.00 |
| May 8, 2025 | UBS | Thomas Wadewitz | Neutral | Maintains | $14.00 |
| May 8, 2025 | Goldman Sachs | Jordan Alliger | Neutral | Maintains | $18.00 |
| Apr 24, 2025 | Truist Securities | Lucas Servera | Buy | Maintains | $19.00 |
| Apr 11, 2025 | Jefferies | Stephanie Moore | Buy | Maintains | $20.00 |
| Apr 10, 2025 | Goldman Sachs | Jordan Alliger | Neutral | Maintains | $21.00 |
| Apr 8, 2025 | Citigroup | Ariel Rosa | Neutral | Maintains | $15.00 |
| Apr 4, 2025 | Oppenheimer | Scott Schneeberger | Perform | Downgrade | $0.00 |
| Apr 2, 2025 | Barclays | Brandon Oglenski | Overweight | Maintains | $22.00 |
| Mar 27, 2025 | Wells Fargo | Christian Wetherbee | Equal-Weight | Maintains | $20.00 |
| Mar 26, 2025 | Susquehanna | Bascome Majors | Negative | Maintains | $13.00 |
| Mar 13, 2025 | Truist Securities | Lucas Servera | Buy | Initiates | $24.00 |
| Feb 6, 2025 | Goldman Sachs | Jordan Alliger | Neutral | Maintains | $24.00 |
| Feb 6, 2025 | Morgan Stanley | Ravi Shanker | Equal-Weight | Maintains | $25.00 |
| Feb 6, 2025 | Stifel | J. Bruce Chan | Hold | Maintains | $24.00 |
| Jan 23, 2025 | Stifel | J. Bruce Chan | Hold | Maintains | $27.00 |
| Jan 17, 2025 | Barclays | Brandon Oglenski | Overweight | Maintains | $30.00 |
| Jan 15, 2025 | Benchmark | Hold | Reiterates | $0.00 |
Rxo Inc. (RXO) Competitors
The following stocks are similar to RXO based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Rxo Inc. (RXO) Financial Data
Rxo Inc. has a market capitalization of $2.83B with a P/E ratio of 645.3x. The company generates $5.07B in trailing twelve-month revenue with a -6.0% profit margin.
Revenue growth is +57.0% quarter-over-quarter, while maintaining an operating margin of -0.7% and return on equity of -28.2%.
Valuation Metrics
Market Cap
$2.83B
Enterprise Value
$3.50B
P/E Ratio
645.3x
PEG Ratio
32.6x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
+57.0%
Gross Margin
+14.0%
Operating Margin
-0.7%
Net Margin
-6.0%
EPS Growth
+57.0%
Financial Health
Cash/Price Ratio
+0.6%
Current Ratio
1.3x
Debt/Equity
43.2x
ROE
-28.2%
ROA
+0.5%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Rxo Inc. (RXO) Business Model
About Rxo Inc.
What They Do
Provides innovative shipping and logistics solutions.
Business Model
The company operates by managing a comprehensive logistics network that includes freight brokerage, last-mile delivery, and managed transportation services. By leveraging technology, Rxo Inc. ensures efficient and cost-effective transportation for a diverse clientele, ranging from small businesses to large enterprises, generating revenue through service fees and contracts.
Additional Information
Rxo Inc. stands out in the industry due to its use of cutting-edge technology for operations, including route optimization and real-time tracking, which enhances customer satisfaction and operational efficiency. The company plays a crucial role in the logistics sector, helping to maintain supply chain integrity while meeting the growing demand for reliable distribution solutions.
Company Information
Sector
Industrials
Industry
Trucking
Employees
7,540
CEO
Mr. Drew M. Wilkerson
Country
United States
IPO Year
2022
Website
www.rxo.comRxo Inc. (RXO) Latest News & Analysis
Latest News
Quick Summary
RXO, Inc. (NYSE:RXO) will hold its Q1 2025 earnings conference call on May 7, 2025, at 8:00 AM ET, featuring key executives and analysts from major financial institutions.
Why It Matters
RXO's upcoming earnings call will provide insights into its financial performance and strategic direction, influencing investor sentiment and stock valuations.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
RXO (NYSE: RXO) reported its Q1 financial results and completed the integration of Coyote operations into the RXO Connect® platform, enhancing operational efficiency.
Why It Matters
RXO's successful migration to the RXO Connect platform enhances operational efficiency, potentially boosting profitability and competitive advantage, which can positively influence stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
RXO reported a quarterly loss of $0.03 per share, slightly worse than the Zacks Consensus Estimate of a loss of $0.02, matching last year's loss of $0.03 per share.
Why It Matters
RXO's larger-than-expected quarterly loss signals potential operational or market challenges, which may lead to negative sentiment and impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
RXO's quarterly performance for March 2025 is reported, with a focus on comparing key metrics to Wall Street estimates and previous year's results.
Why It Matters
RXO's quarterly performance relative to Wall Street estimates and prior year figures impacts its stock valuation and investor sentiment, influencing future investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
RXO may lack the necessary factors for a potential earnings beat in its upcoming report, indicating cautious investor sentiment ahead of the announcement.
Why It Matters
RXO's lack of favorable conditions for an earnings beat may signal weaker financial performance, potentially impacting stock price and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
RXO (NYSE: RXO) executives will present at the Oppenheimer 20th Annual Industrial Growth Conference on May 8, 2025, at 10:30 a.m. EDT. Webcast available at RXO's investor site.
Why It Matters
RXO's participation in a major conference highlights its strategic initiatives and visibility in the market, potentially influencing investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About RXO Stock
What is Rxo Inc.'s (RXO) stock forecast for 2025?
Based on our analysis of 23 Wall Street analysts, Rxo Inc. (RXO) has a median price target of $16.00. The highest price target is $23.00 and the lowest is $10.00.
Is RXO stock a good investment in 2025?
According to current analyst ratings, RXO has 4 Buy ratings, 14 Hold ratings, and 3 Sell ratings. The stock is currently trading at $17.27. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for RXO stock?
Wall Street analysts predict RXO stock could reach $16.00 in the next 12 months. This represents a -7.4% decrease from the current price of $17.27. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Rxo Inc.'s business model?
The company operates by managing a comprehensive logistics network that includes freight brokerage, last-mile delivery, and managed transportation services. By leveraging technology, Rxo Inc. ensures efficient and cost-effective transportation for a diverse clientele, ranging from small businesses to large enterprises, generating revenue through service fees and contracts.
What is the highest forecasted price for RXO Rxo Inc.?
The highest price target for RXO is $23.00 from Jeffrey Kauffman at Vertical Research, which represents a 33.2% increase from the current price of $17.27.
What is the lowest forecasted price for RXO Rxo Inc.?
The lowest price target for RXO is $10.00 from at , which represents a -42.1% decrease from the current price of $17.27.
What is the overall RXO consensus from analysts for Rxo Inc.?
The overall analyst consensus for RXO is neutral. Out of 23 Wall Street analysts, 4 rate it as Buy, 14 as Hold, and 3 as Sell, with a median price target of $16.00.
How accurate are RXO stock price projections?
Stock price projections, including those for Rxo Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 10:16 AM UTC